Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josephine Kang

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Radiation Oncology (London, England)|January 3, 2014
Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year studyAlan Katz, Josephine Kang
Oncoimmunology|August 17, 2017
PD-L1 blockade for urothelial carcinomaJosephine Kang, Lorenzo Galluzzi
Journal of Bacteriology|April 1, 2008
Repair and antirepair DNA helicases in Helicobacter pyloriJosephine Kang, Martin J Blaser
Journal of Bacteriology|July 21, 2006
UvrD helicase suppresses recombination and DNA damage-induced deletionsJosephine Kang, Martin J Blaser
Frontiers in Oncology|November 13, 2014
Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year StudyAlan Jay Katz, Josephine Kang
Nature Reviews. Microbiology|October 17, 2006
Bacterial populations as perfect gases: genomic integrity and diversification tensions in Helicobacter pyloriJosephine Kang, Martin J Blaser
Frontiers in Oncology|September 18, 2014
Stereotactic body radiotherapy as treatment for organ confined low- and intermediate-risk prostate carcinoma, a 7-year studyAlan Jay Katz, Josephine Kang
Seminars in Interventional Radiology|December 19, 2017
Metastatic Osseous Pain Control: Radiation TherapyJosephine Kang, Silvia C Formenti
Journal for Immunotherapy of Cancer|September 24, 2016
Current clinical trials testing the combination of immunotherapy with radiotherapyJosephine Kang, Sandra Demaria, Silvia Formenti
Frontiers in Oncology|July 27, 2016
Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of FailureAlan Katz, Silvia C Formenti, Josephine Kang
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Radiation Oncology (London, England)|January 3, 2014
Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year studyAlan Katz, Josephine Kang
Oncoimmunology|August 17, 2017
PD-L1 blockade for urothelial carcinomaJosephine Kang, Lorenzo Galluzzi
Journal of Bacteriology|April 1, 2008
Repair and antirepair DNA helicases in Helicobacter pyloriJosephine Kang, Martin J Blaser
Journal of Bacteriology|July 21, 2006
UvrD helicase suppresses recombination and DNA damage-induced deletionsJosephine Kang, Martin J Blaser
Frontiers in Oncology|November 13, 2014
Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year StudyAlan Jay Katz, Josephine Kang
Nature Reviews. Microbiology|October 17, 2006
Bacterial populations as perfect gases: genomic integrity and diversification tensions in Helicobacter pyloriJosephine Kang, Martin J Blaser
Frontiers in Oncology|September 18, 2014
Stereotactic body radiotherapy as treatment for organ confined low- and intermediate-risk prostate carcinoma, a 7-year studyAlan Jay Katz, Josephine Kang
Seminars in Interventional Radiology|December 19, 2017
Metastatic Osseous Pain Control: Radiation TherapyJosephine Kang, Silvia C Formenti
Journal for Immunotherapy of Cancer|September 24, 2016
Current clinical trials testing the combination of immunotherapy with radiotherapyJosephine Kang, Sandra Demaria, Silvia Formenti
Frontiers in Oncology|July 27, 2016
Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of FailureAlan Katz, Silvia C Formenti, Josephine Kang
Pageof 4